Publicaties

Publicaties

Artikelen met 1^e, 2^e, één na laatste of laatste TCT auteur 2025

1. Gingele AJ, Amin H, De Wit K, et al. Developing an artificial intelligence-based decision engine for disease-modifying therapy in heart failure: a pilot study. Eur Heart J Digit Health. 2025 Mar;6(2):285-288.
2. Gilbers MD, Kawczynski MJ, Bidar E, et al. Determinants and impact of postoperative atrial fibrillation burden during 2.5 years of continuous rhythm monitoring after cardiac surgery: Results from the RACE V prospective cohort study. Heart Rhythm. 2025 Mar;22(3):647-660.
3. Pinxterhuis TH, Ploumen EH, Kok MM, et al. Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease. Cardiovasc Interv Ther. 2025 Apr;40(2):287-295.
4. Pinxterhuis TH, Ploumen EH, Doggen CJM, et al. Sex and age-specific 10-year mortality after coronary stenting: an analysis of two randomized trials. Eur Heart J Open. 2025 Jan;5(1):oeaf006. 
5. van Vliet D, Ploumen EH, Pinxterhuis TH, et al. Elderly patients treated with Onyx versus Orsiro drug-eluting coronary stents in a randomized clinical trial with long-term follow-up. Clin Res Cardiol. 2025 Dec;114(12):1681-1691.
6. Pinxterhuis TH, von Birgelen C, Ploumen EH, et al. Preferred Treatment and Expected Risk in Coronary Intervention Patients With Peripheral Arterial Disease: Cardiologists’ Views Versus Trials Data. CJC Open. 2025 Jun;7(6):799-806.
7. van Galen DJM, Martins Costa A, Siche-Pantel F, et al. Artificial Placenta and Artificial Womb Technologies for Lung and Kidney Failure: A Holistic Perspective. ASAIO J. 2025 Jul 1;71(7):519-527.
8. Man JP, Bouma BJ, Asselbergs F, et al. Development of an Innovative Pipeline With Fusion, Digital Planning, and Three-Dimensional Printing to Improve Mitral Valve Interventional Care. Echocardiography. 2025 May;42(5):e70184.
9. Jansen C, van der Palen J, Tabak M. Using mobile health to reduce cardiovascular disease risk. BMJ. 2025 May 27;389:r972.
10. Ten Broeke M, Henckens WPR, Weierink A, et al. Brain Pro-TCT: a prospective, quasi-experimental study on early delirium detection with Delirium Observation Screening Scale vs. single-channel EEG after cardiac surgery in patients aged over 70 years. Eur J Cardiovasc Nurs. 2025 May 28;24(4):608-615.
11. van Barreveld M, van Dessel PFHM, Buskens E, Boersma LVA, et al. Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysis. Clin Res Cardiol. 2025 Jun 10.
12. Voortman M, van Es J, von Birgelen C, et al. Clockwise aortic root rotation in patients with tetralogy of fallot assessed with cardiovascular magnetic resonance imaging. Int J Cardiovasc Imaging. 2025 Aug;41(8):1497-1503.
13. Santos K, Oya K, Caldonazo T, Płonek T. En bloc versus branched graft technique for supra-aortic vessel reimplantation in total arch replacement: a systematic review and meta-analysis. J Cardiothorac Surg. 2025 Jun 23;20(1):267.
14. Santos K, Velasco EM, Mawasi M, Płonek T. Unilateral Versus Bilateral Antegrade Cerebral Perfusion in Aortic Arch Surgery: Systematic Review and Meta-Analysis of Randomised Controlled Trials and Propensity-Matched Studies. Heart Lung Circ. 2025 Nov;34(11):1218-1227. 
15. van Vliet D, Pinxterhuis TH, Ploumen EH, Kok MM, et al. Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease – a secondary analysis of the randomized TWENTE trials. Int J Cardiol Heart Vasc. 2025 Aug;59:101741.
16. Plonek T, Mendyka D, Halfwerk FR. No-Touch Aorta Off-Pump LIMA-Radial Artery Y-Graft CABG as a Safe Strategy for All-Comers: Long-Term Survival. J Clin Med. 2025 Jul 9;14(14).
17. Kawczynski MJ, Gilbers MD, Winters J, et al. Right atrial endomysial fibrosis is associated with increased postoperative atrial fibrillation burden during 2.5 years of continuous rhythm monitoring after cardiac surgery including atrial arrhythmia surgery: RACE V Tissue Bank Study. Europace. 2025 Sep 1;27(9).
18. Santos K, Oya K, Umibe T, et al. Does Autologous Platelet-Rich Plasma Improve Blood Conservation and Postoperative Outcomes in Acute Type A Aortic Dissection Surgery? A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth. 2026 Jan;40(1):49-57. 
19. von Birgelen C, van Vliet D. Assessing long-term temporal changes in myocardial infarction treatment and outcomes: chances and challenges. Lancet Reg Health Eur. 2025 Nov;58:101473. 
20. Santos K, Cetinel E, Kim Kim JYB, et al. Does cannulation site affect outcomes of antegrade cerebral perfusion in aortic arch surgery? A meta-analysis of axillary versus innominate access. Perfusion. 2025 Oct 15;:2676591251389386. 
21. van Vliet D, Ploumen EH, Pinxterhuis TH, et al. Complex all-comers and patients with diabetes and prediabetes treated with Xience Sierra everolimus-eluting stents: COASTLINE high-risk. Eur Heart J Open. 2025 Nov;5(6):oeaf140. 
22. Ten Broeke M, Speekenbrink RGH, van der Palen J, Halfwerk FR. Response to the letter to the editor – Brain Pro-TCT: a prospective, quasi-experimental study on early delirium detection with Delirium Observation Screening Scale versus single-channel EEG after cardiac surgery in patients aged over 70 years. Eur J Cardiovasc Nurs. 2025 Oct 22;24(7):1191-1192.
23. Santos K, Campoverde Fárez C, Zecchin Ferrara V, et al. Comparative Outcomes of Right Anterior Minithoracotomy and Ministernotomy for Aortic Valve Replacement: An Updated Meta-Analysis. Innovations (Phila). 2025 Nov-Dec;20(6):534-546.
24. Santos K, Consoli L, de Oliveira LGAM, et al. Operative outcomes following robotic-assisted and conventional minimally invasive mitral valve surgery: A meta-analysis of propensity-matched studies. Asian Cardiovasc Thorac Ann. 2026 Jan;34(1):57-66.
25. Ploumen EH, van Vliet D. SUGAR and stents: evaluating long-term percutaneous coronary intervention outcomes in patients with diabetes. Heart. 2025 Nov 25;111(24):1169-1170.
26. Man JP, Bouma BJ, Molenaar MA, et al. The Prognosis of Males and Females With Moderate or Severe Secondary Mitral Valve Regurgitation and Avenues for Improvement. Echocardiography. 2025 Dec;42(12):e70370.
27. Jansen C, Otterspoor LC, van Pol P, et al. Nationwide Heart Failure Telemonitoring: Disparities in Enrollment Based on Sex. JACC Adv. 2025 Dec 4;5(1):102410.
28. Charell Jansen, Luuk C. Otterspoor, et al. Structuring telemonitoring in heart failure care in The Netherlands: design and operational protocol of a nationwide initiative. European Heart Journal – Digital Health (2025) 00, 1–9 https://doi.org/10.1093/ehjdh/ztaf130.
29. Kristine Santos1, Eren Cetinel, Joo Young Belen, et al. Does preoperative antiplatelet therapy worsen outcomes in acute type A aortic dissection surgery? A meta‑analytic review. The Cardiothoracic Surgeon (2025) 33:25 https://doi.org/10.1186/s43057-025-00171-3.

Artikelen waarbij TCT aan studie heeft bijgedragen via CRE 2025

1. Piccini JP, Patel MR, Steffel J, et al; OCEANIC-AF Steering Committee and Investigators. Asundexianversus Apixaban in Patients with Atrial Fibrillation. N Engl J Med. 2025 Jan 2;392(1):23-32.
2. Aarts HM, Hemelrijk KI, Broeze GM, et al. Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: Rationale and design of the PRO-TAVI trial. Am Heart J. 2025 Mar;281:133-139.
3. Olde Nordkamp LRA, de Veld JA, Ghani A, et al. Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial. Circulation. 2025 Jul 22;152(3):172-182.
4. Selvarajah A, van der Heijden DJ, Remkes WS, et al. Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS Registry. J Clin Med. 2025 Jun 20;14(13).
5. Mensink FB, Los J, Reda Morsy MM, et al. Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial. EuroIntervention. 2025 Aug 18;21(16):910-920.
6. Zannad F, O’Connor CM, Butler J, et al. Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials. Lancet. 2025 Sep 27;406(10510):1351-1362. 
7. Vroomen M, La Meir M, Mokracek A, et al. Epicardial and hybrid surgical ablation of atrial fibrillation: 1-year follow-up outcomes of the EORP EHAFA registry. Europace. 2025 Sep 1;27(9).